Search
for
Sort by
Research 271–300 of 1000+
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Polycystic ovary syndrome and impact on health
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Associaton of Insulin Resistance Linked Diseases and Hair Loss in Elderly Men. Finnish Population-based Study
- Genetic Defects in Human Pericentrin Are Associated With Severe Insulin Resistance and Diabetes
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Endocrine-skin interactions
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Androgens and Antiandrogens
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Anabolic-androgenic steroids and cardiovascular risk
- Side effects of common acne treatments
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Convergent Evolution of Cysteine-Rich Keratins in Hard Skin Appendages of Terrestrial Vertebrates
- Adiponectin Signaling Regulates Lipid Production in Human Sebocytes
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Experimental and Clinical Pharmacology of<i>Ziziphus jujuba</i>Mills
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
- Obesity and the Polycystic Ovary Syndrome
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Whole Genome Scan and Selection Signatures for Climate Adaption in Yanbian Cattle